Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Super Powers

Tim Muller at Crossject has no doubt that supergenerics based on needle-free injection systems will drastically shape the pharma landscape over the next few years. Offering patients greater convenience and control than current generics products, payor benefi ts are likely to be substantial.

Tim Muller, Crossject (December 2014)

Keywords: Biosimilars and generics, Injectable delivery systems, Supergenerics market, Needle-free technology

    View full article    |    Back to Delivery systems section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |